Predicting metachronous liver metastasis from colorectal cancer using serum proteomic fingerprinting

Journal of Surgical Research

Volumn 184, Issue 2, 2013, Pages 861-866

  Zhu, Dexiang ^a   Zhong, Yunshi ^a   Wu, Haifu ^a   Ye, Lechi ^a   Wang, Jie ^b   Li, Yan ^c   Wei, Ye ^a   Ren, Li ^a   Xu, Bin ^b   Xu, Jianmin ^a   Qin, Xinyu ^a  

^a FUDAN UNIVERSITY   (China)

^b NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

^c Bioyong (Beijing) Technology Co Ltd   (China)

Author keywords

Metachronous liver metastasis; Proteomics; Serum proteomic fingerprinting

Indexed keywords

ALPHA FETOPROTEIN; ANGIOTENSINOGEN; CARCINOEMBRYONIC ANTIGEN; COMPLEMENT COMPONENT C4A; EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR GTP BINDING SUBUNIT ERF3B; FIBRINOGEN; FIBRINOGEN ALPHA; GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CANCER RECURRENCE; CANCER STAGING; CHEMICAL INDUSTRY; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; COLORECTAL SURGERY; CONTROLLED STUDY; DECISION TREE; DNA FINGERPRINTING; FEMALE; FIBRINOGEN BLOOD LEVEL; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METACHRONOUS LIVER METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMIC FINGERPRINTING; PROTEOMICS; RECTUM CARCINOMA; SIGMOID; SIGMOID CARCINOMA; TUMOR LOCALIZATION;

METACHRONOUS LIVER METASTASIS; PROTEOMICS; SERUM PROTEOMIC FINGERPRINTING;

AGED; ALPHA-FETOPROTEINS; ANGIOTENSINOGEN; COLORECTAL NEOPLASMS; COMPLEMENT C4A; DECISION SUPPORT TECHNIQUES; FEMALE; FIBRINOGEN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PEPTIDE MAPPING; PEPTIDE TERMINATION FACTORS; PREDICTIVE VALUE OF TESTS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84883894270     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.04.065     Document Type: Article

References (19)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69
2. G. Li Destri, A. Di Cataldo, and S. Puleo Colorectal cancer follow-up: useful or useless? Surg Oncol 15 2006 1
3. C. Compton, C.M. Fenoglio-Preiser, N. Pettigrew, and L.P. Fielding American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group Cancer 88 2000 1739
4. V. Kulasingam, and E.P. Diamandis Strategies for discovering novel cancer biomarkers through utilization of emerging technologies Nat Clin Pract Oncol 5 2008 588
5. C.F. Peeters, R.M. de Waal, T. Wobbes, J.R. Westphal, and T.J. Ruers Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation Int J Cancer 119 2006 1249
6. N. Wang, F.T. Dong, and X.M. Zhang Hydrothermal synthesis of metal-chelated magnetic nanobeads for exclusive use of peptides extraction by mass spectrum Acta Chim Sinica 65 2007 344
7. N.C. Bird, D. Mangnall, and A.W. Majeed Biology of colorectal liver metastases: a review J Surg Oncol 94 2006 68
8. A. Govindarajan, and P.B. Paty Predictive markers of colorectal cancer liver metastases Future Oncol 7 2011 299
9. M.J. Duffy, A. van Dalen, and C. Haglund Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use Eur J Cancer 43 2007 1348
10. S.M. Hanash, S.J. Pitteri, and V.M. Faca Mining the plasma proteome for cancer biomarkers Nature 452 2008 571
11. E.F. Petricoin, C. Belluco, R.P. Araujo, and L.A. Liotta The blood peptidome: a higher dimension of information content for cancer biomarker discovery Nat Rev Cancer 6 2006 961
12. A.J. Cheng, L.C. Chen, and K.Y. Chien Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology Clin Chem 51 2005 2236
13. K. Schwamborn, R.C. Krieg, and J. Grosse Serum proteomic profiling in patients with bladder cancer Eur Urol 56 2009 989
14. P. Bertone, Y. Kluger, and N. Lan SPINE: an integrated tracking database and data mining approach for identifying feasible targets in high-throughput structural proteomics Nucleic Acids Res 29 2001 2884
15. J.M. Luk, B.Y. Lam, and N.P. Lee Artificial neural networks and decision tree model analysis of liver cancer proteomes Biochem Biophys Res Commun 361 2007 68
16. E.F. Patz Jr., M.J. Campa, E.B. Gottlin, I. Kusmartseva, X.R. Guan, and J.E. Herndon 2nd Panel of serum biomarkers for the diagnosis of lung cancer J Clin Oncol 25 2007 5578
17. J. Villanueva, D.R. Shaffer, and J. Philip Differential exoprotease activities confer tumor-specific serum peptidome patterns J Clin Invest 116 2006 271
18. S. Yachida, N. Fukushima, and Y. Nakanishi Alpha-fetoprotein-producing carcinoma of the colon: report of a case and review of the literature Dis Colon Rectum 46 2003 826
19. K. Fu, A. Kobayashi, and N. Saito Alpha-fetoprotein-producing colon cancer with atypical bulky lymph node metastasis World J Gastroenterol 12 2006 7715